AFT Pharmaceuticals Ltd

AFT Pharmaceuticals Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (NZD)3.32
  • Today's Change0.02 / 0.61%
  • Shares traded1.18k
  • 1 Year change-8.54%
  • Beta0.4758
Data delayed at least 20 minutes, as of Mar 29 2023 21:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AFT Pharmaceuticals Limited is a New Zealand-based multinational pharmaceutical company. The Company develops, markets and distributes a portfolio of pharmaceutical products across a range of therapeutic categories around the world. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's product portfolio targets various therapeutic areas, such as pain, eyecare, vitamins, allergy, gastrointestinal, dermatology and hospital. Its products include Maxigesic, ParaOsteo, ZoRub OA/HP, Fenpaed, Combolieve Day/Night, Hylo, Novatears, CromoFresh, Opti-soothe Wipes/Mask, VitAPOS, Ferro-liquid, FerroTab, Ferro-F, Ferro-sachets, Lipo VitC, Lipo VitD, CalciTab, Loraclear, Histaclear, Fexaclear, Levoclear, Allersoothe, Lorapaed, Becloclear, Steroclear, Gastrosoothe/Forte, LaxTab, Micolette, Nausicalm, DiaRelieve, Crystaderm, Crystawash Hand Sanitizer, Crystasoothe, ZoRub anti-chafing, Decazol, MycoNail and others.

  • Revenue in NZD (TTM)140.55m
  • Net income in NZD17.06m
  • Incorporated1997
  • Employees107.00
  • Location
    AFT Pharmaceuticals LtdLevel 1, 129 Hurstmere RoadAUCKLAND 0622New ZealandNZL
  • Phone+64 94880232
  • Fax+64 94880234
  • Websitehttp://www.aftpharm.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Fuji Pharma Co., Ltd.439.57m32.89m336.03m1.56k10.030.70274.960.7644110.81110.811,480.811,580.960.49711.512.5523,061,540.003.724.485.325.8940.5542.807.497.640.8779--0.437530.864.220.02210.86-3.9751.787.84
Amrutanjan Health Care Ltd75.07m8.14m337.87m647.0041.61--37.004.5014.3014.30131.85--------5,964,019.00--18.30--22.8253.1154.9710.8413.46--118.34--21.8321.9313.329.8023.7943.8933.13
AVE Science & Technology Co Ltd48.51m6.43m338.95m508.0052.683.03--6.990.40680.40683.077.070.39162.2322.36410,547.705.19--5.66--52.87--13.26--5.86--0.00--16.91--3.90------
Gufic BioSciences Ltd132.24m15.93m339.38m1.38k21.30--17.472.578.458.4570.14--------4,918,800.00--12.07--26.7852.8244.4512.048.73--19.67--1.5459.7624.51116.6860.4284.5414.87
Mayne Pharma Group Ltd356.56m-366.50m346.06m900.00--0.4157--0.9706-4.120.9654.019.050.22442.021.54---23.77-11.77-30.34-13.8627.8050.88-105.94-41.981.15-5.070.0924--5.93-5.78-26.33---59.47--
Koa Shoji Holdings Co Ltd258.61m28.79m347.10m303.0012.061.459.341.3459.4759.47534.22493.650.79336.182.3969,851,920.008.836.6911.068.4228.2027.7011.139.063.2768.980.145921.4614.246.1110.4115.59-26.49--
AFT Pharmaceuticals Ltd140.55m17.06m351.30m107.0020.316.0118.882.500.16490.16491.350.55711.212.085.221,313,561.0014.706.2523.3210.2445.3645.5712.144.880.62117.090.41420.0015.2213.49161.36--49.74--
Jacobson Pharma Corporation Ltd338.67m47.63m362.50m1.80k7.540.69264.041.070.12190.12190.86721.330.33612.805.95957,651.505.104.966.656.8841.3941.4115.1713.743.0910.160.341432.4610.354.902.28-0.186-7.1112.02
Data as of Mar 29 2023. Currency figures normalised to AFT Pharmaceuticals Ltd's reporting currency: New Zealand Dollar NZD

Institutional shareholders

6.22%Per cent of shares held by top holders
HolderShares% Held
Accident Compensation Corp.as of 30 Apr 20224.78m4.56%
Guardians of New Zealand Superannuationas of 30 Apr 20221.65m1.57%
FCA Corp.as of 31 Jan 202346.00k0.04%
Dimensional Fund Advisors LPas of 02 Mar 202342.87k0.04%
More ▼
Data from 30 Jun 2022 - 23 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.